Kissei Pharmaceutical Co., Ltd.
4547.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥25 | ¥23 | ¥26 | ¥30 |
| Short-Term Investments | ¥23 | ¥23 | ¥24 | ¥23 |
| Receivables | ¥30 | ¥29 | ¥23 | ¥23 |
| Inventory | ¥25 | ¥26 | ¥23 | ¥19 |
| Other Curr. Assets | ¥4 | ¥4 | ¥5 | ¥4 |
| Total Curr. Assets | ¥107 | ¥105 | ¥101 | ¥99 |
| Property Plant & Equip (Net) | ¥27 | ¥25 | ¥25 | ¥24 |
| Goodwill | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥2 | ¥2 | ¥2 | ¥2 |
| Long-Term Investments | ¥85 | ¥106 | ¥51 | ¥97 |
| Tax Assets | ¥1 | ¥1 | ¥0 | ¥1 |
| Other NC Assets | ¥23 | ¥23 | ¥43 | ¥16 |
| Total NC Assets | ¥137 | ¥156 | ¥121 | ¥139 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥244 | ¥261 | ¥221 | ¥238 |
| Liabilities | – | – | – | – |
| Payables | ¥5 | ¥5 | ¥5 | ¥4 |
| Short-Term Debt | ¥1 | ¥1 | ¥1 | ¥2 |
| Tax Payable | ¥0 | ¥2 | ¥0 | ¥3 |
| Deferred Revenue | ¥1 | ¥1 | ¥4 | ¥8 |
| Other Curr. Liab. | ¥10 | ¥8 | ¥4 | ¥1 |
| Total Curr. Liab. | ¥17 | ¥18 | ¥15 | ¥19 |
| LT Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥16 | ¥21 | ¥10 | ¥16 |
| Other NC Liab. | ¥1 | ¥1 | ¥1 | ¥1 |
| Total NC Liab. | ¥17 | ¥22 | ¥11 | ¥17 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liabilities | ¥34 | ¥40 | ¥26 | ¥36 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥161 | ¥154 |
| Common Stock | ¥24 | ¥24 | ¥24 | ¥24 |
| Retained Earnings | ¥131 | ¥127 | ¥126 | ¥118 |
| AOCI | ¥43 | ¥57 | ¥33 | ¥48 |
| Other Equity | ¥10 | ¥11 | ¥11 | ¥11 |
| Total Equity | ¥209 | ¥220 | ¥194 | ¥201 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥1 | ¥1 | ¥1 | ¥1 |
| Total Liab. & Tot. Equity | ¥244 | ¥261 | ¥221 | ¥238 |
| Net Debt | -¥24 | -¥22 | -¥24 | -¥28 |